• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD56+树突状样细胞的特征:母细胞样浆细胞样树突状细胞瘤的正常对应物?

Characterization of CD56+ dendritic-like cells: a normal counterpart of blastic plasmacytoid dendritic cell neoplasm?

作者信息

Osaki Yohei, Yokohama Akihiko, Saito Akio, Tahara Kenichi, Yanagisawa Kunio, Ogawa Yoshiyuki, Ishizaki Takuma, Mitsui Takeki, Koiso Hiromi, Takizawa Makiko, Uchiumi Hideki, Saitoh Takayuki, Handa Hiroshi, Murakami Hirokazu, Tsukamoto Norifumi, Nojima Yoshihisa

机构信息

Department of Medicine and Clinical Science, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.

出版信息

PLoS One. 2013 Nov 29;8(11):e81722. doi: 10.1371/journal.pone.0081722. eCollection 2013.

DOI:10.1371/journal.pone.0081722
PMID:24312342
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3843704/
Abstract

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematological malignancy. Plasmacytoid DCs (pDCs), which are defined as lineage marker (Lin)(-)HLA-DR(+)CD56(-)CD123(+)CD11c(-) cells, are considered to be the normal counterpart of BPDCNs. However, BPDCN can be distinguished from pDCs by uniform expression of CD56. In this study, to identify a normal counterpart of BPDCN, we searched for a Lin(-)HLA-DR(+)CD56(+) population and focused on a minor subpopulation of Lin(-)DR(+)CD56(+)CD123(+)CD11c(-) cells that we designated as pDC-like cells (pDLCs). pDLC constituted 0.03% of peripheral blood mononuclear cells (PBMCs), and the pDLC/pDC ratio was higher in bone marrow cells than in PBMCs. pDLC clearly expressed BDCA2, BDCA4, and myeloid antigens, which are frequently expressed by BPDCN. pDLCs exhibited modest expression of Toll-like receptors and produced less interferon-α after CpG stimulation, but presented very low endocytic ability unlike mDCs. These functional differences were attributed to the expression profile of transcriptional factors. After in vitro culture with Flt3-ligand and GM-CSF, pDLCs expressed CD11c and BDCA1. These data suggested that pDLCs are a distinct subpopulation, with an immunophenotype similar to BPDCNs. Moreover, our results indicate that pDLCs might be immature DCs and might contribute to the immunophenotypical diversity of BPDCNs.

摘要

母细胞样浆细胞样树突状细胞肿瘤(BPDCN)是一种罕见的血液系统恶性肿瘤。浆细胞样树突状细胞(pDC)被定义为谱系标志物(Lin)(-)HLA-DR(+)CD56(-)CD123(+)CD11c(-)细胞,被认为是BPDCN的正常对应物。然而,BPDCN可通过CD56的均匀表达与pDC区分开来。在本研究中,为了确定BPDCN的正常对应物,我们寻找了Lin(-)HLA-DR(+)CD56(+)群体,并关注Lin(-)DR(+)CD56(+)CD123(+)CD11c(-)细胞的一个小亚群,我们将其命名为pDC样细胞(pDLC)。pDLC占外周血单个核细胞(PBMC)的0.03%,骨髓细胞中的pDLC/pDC比值高于PBMC。pDLC明显表达BDCA2、BDCA4和髓系抗原,这些抗原在BPDCN中经常表达。pDLCs表现出适度的Toll样受体表达,在CpG刺激后产生较少的干扰素-α,但与mDCs不同,其吞噬能力非常低。这些功能差异归因于转录因子的表达谱。在用Flt3配体和GM-CSF进行体外培养后,pDLCs表达CD11c和BDCA1。这些数据表明pDLCs是一个独特的亚群,其免疫表型与BPDCN相似。此外,我们的结果表明pDLCs可能是未成熟的DCs,可能有助于BPDCNs的免疫表型多样性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aca5/3843704/c58b803c8d92/pone.0081722.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aca5/3843704/8d12aed8a71d/pone.0081722.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aca5/3843704/517b419c8d4e/pone.0081722.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aca5/3843704/a4d0bff9a9c8/pone.0081722.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aca5/3843704/43a6f7fdf8f3/pone.0081722.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aca5/3843704/c58b803c8d92/pone.0081722.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aca5/3843704/8d12aed8a71d/pone.0081722.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aca5/3843704/517b419c8d4e/pone.0081722.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aca5/3843704/a4d0bff9a9c8/pone.0081722.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aca5/3843704/43a6f7fdf8f3/pone.0081722.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aca5/3843704/c58b803c8d92/pone.0081722.g005.jpg

相似文献

1
Characterization of CD56+ dendritic-like cells: a normal counterpart of blastic plasmacytoid dendritic cell neoplasm?CD56+树突状样细胞的特征:母细胞样浆细胞样树突状细胞瘤的正常对应物?
PLoS One. 2013 Nov 29;8(11):e81722. doi: 10.1371/journal.pone.0081722. eCollection 2013.
2
Human BDCA2+CD123+CD56+ dendritic cells (DCs) related to blastic plasmacytoid dendritic cell neoplasm represent a unique myeloid DC subset.与母细胞样浆细胞样树突状细胞肿瘤相关的人类BDCA2+CD123+CD56+树突状细胞(DCs)代表一种独特的髓样DC亚群。
Protein Cell. 2015 Apr;6(4):297-306. doi: 10.1007/s13238-015-0140-x. Epub 2015 Mar 18.
3
Myeloid Neoplasms with Elevated Plasmacytoid Dendritic Cell Differentiation Reflect the Maturation Process of Dendritic Cells.具有浆细胞样树突状细胞分化增加的髓系肿瘤反映了树突状细胞的成熟过程。
Cytometry A. 2020 Jan;97(1):61-69. doi: 10.1002/cyto.a.23953. Epub 2019 Dec 26.
4
Clinicopathological analysis of 46 cases with CD4 and/or CD56 immature haematolymphoid malignancy: reappraisal of blastic plasmacytoid dendritic cell and related neoplasms.46 例 CD4 和/或 CD56 幼稚血液淋巴恶性肿瘤的临床病理分析:对原始浆细胞样树突状细胞肿瘤及相关肿瘤的再评估。
Histopathology. 2017 Dec;71(6):972-984. doi: 10.1111/his.13340. Epub 2017 Oct 10.
5
Blastic Plasmacytoid Dendritic Cell Neoplasm: Progress in Cell Origin, Molecular Biology, Diagnostic Criteria and Therapeutic Approaches.原始滤泡性淋巴瘤:细胞起源、分子生物学、诊断标准和治疗方法的进展。
Curr Med Sci. 2021 Jun;41(3):405-419. doi: 10.1007/s11596-021-2393-3. Epub 2021 Jul 3.
6
Expanding the Immunophenotypic Spectrum of Neoplastic and Reactive Plasmacytoid Dendritic Cells.扩展肿瘤性和反应性浆细胞样树突状细胞的免疫表型谱。
Am J Clin Pathol. 2023 May 2;159(5):455-463. doi: 10.1093/ajcp/aqac174.
7
Immunophenotypic characterization of reactive and neoplastic plasmacytoid dendritic cells permits establishment of a 10-color flow cytometric panel for initial workup and residual disease evaluation of blastic plasmacytoid dendritic cell neoplasm.反应性和肿瘤性浆细胞样树突状细胞的免疫表型特征有助于建立 10 色流式细胞术面板,用于初始检查和浆母细胞样树突状细胞瘤残留疾病的评估。
Haematologica. 2021 Apr 1;106(4):1047-1055. doi: 10.3324/haematol.2020.247569.
8
Immunophenotypic and Molecular Features of Acute Myeloid Leukemia with Plasmacytoid Dendritic Cell Differentiation Are Distinct from Blastic Plasmacytoid Dendritic Cell Neoplasm.具有浆细胞样树突状细胞分化的急性髓系白血病的免疫表型和分子特征与母细胞性浆细胞样树突状细胞肿瘤不同。
Cancers (Basel). 2022 Jul 11;14(14):3375. doi: 10.3390/cancers14143375.
9
Isolation and characterization of plasmacytoid dendritic cells from Flt3 ligand and granulocyte-macrophage colony-stimulating factor-treated mice.从经Flt3配体和粒细胞巨噬细胞集落刺激因子处理的小鼠中分离并鉴定浆细胞样树突状细胞。
Blood. 2001 Dec 15;98(13):3520-6. doi: 10.1182/blood.v98.13.3520.
10
E-Cadherin Expression and Blunted Interferon Response in Blastic Plasmacytoid Dendritic Cell Neoplasm.E-钙黏蛋白表达和幼稚浆细胞样树突状细胞瘤干扰素反应迟钝。
Am J Surg Pathol. 2021 Oct 1;45(10):1428-1438. doi: 10.1097/PAS.0000000000001747.

引用本文的文献

1
Flow Cytometry Profiling of Plasmacytoid Dendritic Cell Neoplasms.浆细胞样树突状细胞瘤的流式细胞术分析
Cancers (Basel). 2024 Jun 1;16(11):2118. doi: 10.3390/cancers16112118.
2
Research Progress of Dendritic Cell Surface Receptors and Targeting.树突状细胞表面受体与靶向性的研究进展
Biomedicines. 2023 Jun 9;11(6):1673. doi: 10.3390/biomedicines11061673.
3
Immunophenotypic characterization of reactive and neoplastic plasmacytoid dendritic cells permits establishment of a 10-color flow cytometric panel for initial workup and residual disease evaluation of blastic plasmacytoid dendritic cell neoplasm.

本文引用的文献

1
Human plasmacytoid dendritic cells are equipped with antigen-presenting and tumoricidal capacities.人浆细胞样树突状细胞具有抗原呈递和杀肿瘤能力。
Blood. 2012 Nov 8;120(19):3936-44. doi: 10.1182/blood-2012-06-435941. Epub 2012 Sep 10.
2
Circulating plasmacytoid dendritic cells in patients with primary and Helicobacter pylori-associated immune thrombocytopenia.原发性和幽门螺杆菌相关免疫性血小板减少症患者的循环浆细胞样树突状细胞。
Eur J Haematol. 2012 Apr;88(4):340-9. doi: 10.1111/j.1600-0609.2011.01745.x. Epub 2012 Feb 2.
3
Cutaneous accumulation of plasmacytoid dendritic cells associated with acute myeloid leukemia: a rare condition distinct from blastic plasmacytoid dendritic cell neoplasm.
反应性和肿瘤性浆细胞样树突状细胞的免疫表型特征有助于建立 10 色流式细胞术面板,用于初始检查和浆母细胞样树突状细胞瘤残留疾病的评估。
Haematologica. 2021 Apr 1;106(4):1047-1055. doi: 10.3324/haematol.2020.247569.
4
Blastic Plasmacytoid Dendritic Cell Neoplasia: A Single Center Experience.母细胞性浆细胞样树突状细胞肿瘤:单中心经验
Turk J Haematol. 2020 Feb 20;37(1):48-52. doi: 10.4274/tjh.galenos.2019.2019.0195. Epub 2019 Nov 22.
5
Human dendritic cell subsets: an update.人类树突状细胞亚群:更新。
Immunology. 2018 May;154(1):3-20. doi: 10.1111/imm.12888. Epub 2018 Feb 27.
6
Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors.单细胞RNA测序揭示了人类血液中新型树突状细胞、单核细胞和祖细胞。
Science. 2017 Apr 21;356(6335). doi: 10.1126/science.aah4573.
7
Haploinsufficiency for NR3C1, the gene encoding the glucocorticoid receptor, in blastic plasmacytoid dendritic cell neoplasms.编码糖皮质激素受体的基因NR3C1在母细胞样浆细胞样树突状细胞瘤中的单倍剂量不足。
Blood. 2016 Jun 16;127(24):3040-53. doi: 10.1182/blood-2015-09-671040. Epub 2016 Apr 8.
8
Blastic plasmacytoid dendritic neoplasm (BPDN) or BPDN-like lesion presenting after influenza vaccination and resolving with topical high potency steroid.在流感疫苗接种后出现并经局部强效类固醇治疗后消退的母细胞性浆细胞样树突状细胞瘤(BPDN)或BPDN样病变
JAAD Case Rep. 2015 Jun 13;1(4):203-6. doi: 10.1016/j.jdcr.2015.04.010. eCollection 2015 Jul.
9
Human dendritic cell subsets and function in health and disease.人类树突状细胞亚群及其在健康与疾病中的功能。
Cell Mol Life Sci. 2015 Nov;72(22):4309-25. doi: 10.1007/s00018-015-2005-0. Epub 2015 Aug 5.
10
Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients.针对白细胞介素-3受体的靶向疗法SL-401在母细胞样浆细胞样树突状细胞肿瘤患者中的活性。
Blood. 2014 Jul 17;124(3):385-92. doi: 10.1182/blood-2014-04-566737. Epub 2014 May 23.
与急性髓系白血病相关的浆细胞样树突状细胞皮肤聚集:一种不同于母细胞性浆细胞样树突状细胞肿瘤的罕见病症。
J Cutan Pathol. 2011 Nov;38(11):893-8. doi: 10.1111/j.1600-0560.2011.01777.x. Epub 2011 Aug 23.
4
Blastic plasmacytoid dendritic cell neoplasm expressing the CD13 myeloid antigen.表达 CD13 髓样抗原的母细胞样浆细胞性树突细胞肿瘤。
Acta Haematol. 2011;126(2):122-8. doi: 10.1159/000328180. Epub 2011 Jun 24.
5
IL-2 costimulation enables statin-mediated activation of human NK cells, preferentially through a mechanism involving CD56+ dendritic cells.白介素-2(IL-2)共刺激可使他汀类药物介导的人自然杀伤(NK)细胞激活,这一过程主要通过一种涉及 CD56+树突状细胞的机制来实现。
Cancer Res. 2010 Dec 1;70(23):9611-20. doi: 10.1158/0008-5472.CAN-10-1968. Epub 2010 Oct 14.
6
The transcription factor PU.1 controls dendritic cell development and Flt3 cytokine receptor expression in a dose-dependent manner.转录因子 PU.1 以剂量依赖的方式控制树突状细胞的发育和 Flt3 细胞因子受体的表达。
Immunity. 2010 May 28;32(5):628-41. doi: 10.1016/j.immuni.2010.05.005.
7
Transformation of dendritic cells from plasmacytoid to myeloid in a leukemic plasmacytoid dendritic cell line (PMDC05).在白血病浆细胞样树突状细胞系(PMDC05)中,树突状细胞从浆细胞样向髓样的转化。
Leuk Res. 2010 Nov;34(11):1517-24. doi: 10.1016/j.leukres.2010.03.002. Epub 2010 Mar 24.
8
In vivo analysis of dendritic cell development and homeostasis.树突状细胞发育与稳态的体内分析。
Science. 2009 Apr 17;324(5925):392-7. doi: 10.1126/science.1170540. Epub 2009 Mar 12.
9
Plasmacytoid dendritic cell leukemia with potent antigen-presenting ability.具有强大抗原呈递能力的浆细胞样树突状细胞白血病。
Acta Haematol. 2008;120(2):91-9. doi: 10.1159/000165510. Epub 2008 Oct 24.
10
Development of human plasmacytoid dendritic cells depends on the combined action of the basic helix-loop-helix factor E2-2 and the Ets factor Spi-B.人类浆细胞样树突状细胞的发育依赖于碱性螺旋-环-螺旋因子E2-2和Ets因子Spi-B的联合作用。
Eur J Immunol. 2008 Sep;38(9):2389-400. doi: 10.1002/eji.200838470.